OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
Yifan Cao, Kuan Yu, Zihao Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 7
Yifan Cao, Kuan Yu, Zihao Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 7
Showing 7 citing articles:
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
Yibo He, Qianran Hong, Shiliang Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Yibo He, Qianran Hong, Shiliang Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer
Wanqian Liao, Yu Wang, Rui Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1089-1089
Open Access
Wanqian Liao, Yu Wang, Rui Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1089-1089
Open Access
Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside
Yiming Luo, Ye Yuan, Shilin Liu, et al.
Trends in cancer (2025)
Open Access
Yiming Luo, Ye Yuan, Shilin Liu, et al.
Trends in cancer (2025)
Open Access
A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update
Gabriel Samaşcă, Claudia Burz, Irena Pintea, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1121-1121
Open Access
Gabriel Samaşcă, Claudia Burz, Irena Pintea, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1121-1121
Open Access
